Template:Zika virus: Difference between revisions

Sexually transmitted diseases Main Page
	Zika virus infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Classification
Differentiating Zika Virus Infection from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Evaluation of Pregnant Women
Evaluation of Infants
Collection and Submission of Fetal Tissues
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission
Secondary Prevention
CDC Response Planning Tips
Risk-based Preparedness for States
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Zika virus On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Zika virus All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Zika virus
CDC on Zika virus
Zika virus in the news
Blogs on Zika virus
Directions to Hospitals Treating Zika virus infection
Risk calculators and risk factors for Zika virus

@@ Line 1: / Line 1: @@
 {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
+|- bgcolor="LightGrey"
+!
+[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
+|-
+!
 |-
 | colspan="1" style="text-align:center; background:DarkGray" |
@@ Line 118: / Line 125: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Zika virus infection sexual transmission risk assessment|Sexual Transmission Risk Assessment]]
+[[Zika virus infection other diagnostic studies|Other Diagnostic Studies]]
 |-
 !
@@ Line 142: / Line 149: @@
 |- bgcolor="PaleTurquoise"
 !
-[[Zika virus infection prevention|Prevention]]
+[[Zika virus infection prevention|Primary Prevention]]
 |-
 !
@@ Line 163: / Line 170: @@
 |-
 !
+|- bgcolor="PaleTurquoise"
+!
+::[[Zika virus infection sexual transmission |Sexual transmission]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Zika virus secondary prevention |Secondary Prevention]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Zika virus infection response planning tips|CDC Response Planning Tips]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+[[Zika virus infection risk-based preparedness|Risk-based Preparedness for States]]
+|-
+!
 |- bgcolor="PaleTurquoise"
@@ Line 168: / Line 199: @@
 [[Zika virus infection cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
 |-
 !
 |- bgcolor="PaleTurquoise"

Latest revision as of 16:34, 2 March 2017